In Brief: Bioxodes To Take Novel Hemorrhagic Stroke Drug Into Registrational Trial

There are currently no approved treatments for ICH

 
• By Sushmita Panda
  
Brain Stroke
ICH is a devastating condition, which while accounting for only 13% of all cases of stroke, is behind 40% of all stroke-related deaths. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Neurological